Search research articles
Contact Us
Filters
Showing results (451-460 of 476) with videos related to
Page
of 48
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
September 11, 2025
Dextromethorphan/quinidine (DMQ) for reducing bulbar symptoms in amyotrophic lateral sclerosis - assessment of treatment experience in a multicenter study
Susanne Spittel, Torsten Grehl, Patrick Weydt, et al.
Journal of Neurology
|
August 14, 2024
Clinical characterization of common pathogenic variants of SOD1-ALS in Germany
Maximilian Wiesenfarth, Yalda Forouhideh-Wiesenfarth, Zeynep Elmas, et al.
Annals of Surgery
|
August 2, 2021
Neoadjuvant Therapy for Resectable Pancreatic Cancer: A New Standard of Care. Pooled Data From 3 Randomized Controlled Trials
Dominique L Birrer, Henriette Golcher, Riccardo Casadei, et al.
Psychosomatic Medicine
|
January 14, 2023
Type D Personality as a Risk Factor for Adverse Outcome in Patients With Cardiovascular Disease: An Individual Patient-Data Meta-analysis
Paul Lodder, Jelte M Wicherts, Marijn Antens, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
December 13, 2016
Sequence variations in C9orf72 downstream of the hexanucleotide repeat region and its effect on repeat-primed PCR interpretation: a large multinational screening study
Angelica Nordin, Chizuru Akimoto, Anna Wuolikainen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 14, 2018
Comprehensive analysis of the mutation spectrum in 301 German ALS families
Kathrin Müller, David Brenner, Patrick Weydt, et al.
Plos One
|
May 21, 2014
Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trial
Vincent Meininger, Pierre-François Pradat, Andrea Corse, et al.
European Journal of Neurology
|
June 11, 2024
Serum neurofilament light chain in distinct phenotypes of amyotrophic lateral sclerosis: A longitudinal, multicenter study
Thomas Meyer, Marie Dreger, Torsten Grehl, et al.
The Lancet. Neurology
|
October 18, 2024
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial
Jan C Koch, Andreas Leha, Helen Bidner, et al.
Journal of Neurology
|
March 30, 2019
Prognostic factors in ALS: a comparison between Germany and China
Johannes Dorst, Lu Chen, Angela Rosenbohm, et al.
Page
of 48
Search research articles
Search
Showing results (451-460 of 476) with videos related to
Sort By:
Page
of 48
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
September 11, 2025
Dextromethorphan/quinidine (DMQ) for reducing bulbar symptoms in amyotrophic lateral sclerosis - assessment of treatment experience in a multicenter study
Susanne Spittel, Torsten Grehl, Patrick Weydt, et al.
Journal of Neurology
|
August 14, 2024
Clinical characterization of common pathogenic variants of SOD1-ALS in Germany
Maximilian Wiesenfarth, Yalda Forouhideh-Wiesenfarth, Zeynep Elmas, et al.
Annals of Surgery
|
August 2, 2021
Neoadjuvant Therapy for Resectable Pancreatic Cancer: A New Standard of Care. Pooled Data From 3 Randomized Controlled Trials
Dominique L Birrer, Henriette Golcher, Riccardo Casadei, et al.
Psychosomatic Medicine
|
January 14, 2023
Type D Personality as a Risk Factor for Adverse Outcome in Patients With Cardiovascular Disease: An Individual Patient-Data Meta-analysis
Paul Lodder, Jelte M Wicherts, Marijn Antens, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
December 13, 2016
Sequence variations in C9orf72 downstream of the hexanucleotide repeat region and its effect on repeat-primed PCR interpretation: a large multinational screening study
Angelica Nordin, Chizuru Akimoto, Anna Wuolikainen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 14, 2018
Comprehensive analysis of the mutation spectrum in 301 German ALS families
Kathrin Müller, David Brenner, Patrick Weydt, et al.
Plos One
|
May 21, 2014
Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trial
Vincent Meininger, Pierre-François Pradat, Andrea Corse, et al.
European Journal of Neurology
|
June 11, 2024
Serum neurofilament light chain in distinct phenotypes of amyotrophic lateral sclerosis: A longitudinal, multicenter study
Thomas Meyer, Marie Dreger, Torsten Grehl, et al.
The Lancet. Neurology
|
October 18, 2024
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial
Jan C Koch, Andreas Leha, Helen Bidner, et al.
Journal of Neurology
|
March 30, 2019
Prognostic factors in ALS: a comparison between Germany and China
Johannes Dorst, Lu Chen, Angela Rosenbohm, et al.
Page
of 48